Allied Market Research

2024

Gastrointestinal Otc Drugs Market

Gastrointestinal OTC Drugs Market Size, Share, Competitive Landscape and Trend Analysis Report by Product (Laxatives, Gastrointestinal Cancer Treatments, Gastric Acid Reducers, Anti-Diarrheal, Proton Pump Inhibitors, H2 Inhibitors, Gastric Acid Neutralizers, Bowel Anti-Inflammatory, Anti-Emetics), by Indication (Gastroesophageal Reflux Disease (GERD) or Heartburn, Constipation, Diarrhea, Motion Sickness, Flatulence) and by End User (Clinics, Pharmacies, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Gastrointestinal diseases include complications related to the stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver, and pancreas. Gastrointestinal over the counter (OTC) drugs are medications that can be bought without any doctors prescription and are used to control vomiting, constipation, diarrhea, and flatulence.

The major factors that contribute to the growth of the gastrointestinal OTC drugs market include the increasing prevalence of gastrointestinal diseases, high adoption of OTC drugs as they are cost-effective & convenient to buy, advancements in R&D activities such as innovations in drugs, and high demand for self-diagnosis and self-medication. However, factors such as stringent government regulations and inadequate reimbursements provided for gastrointestinal OTC drugs hinder the market growth. Conversely, growth in public awareness and increase in healthcare expenditures are expected to provide numerous opportunities for the market growth in the near future.

The global gastrointestinal OTC drugs market is segmented on the basis of product, indication, end user, and region. On the basis of product, the market is segmented into laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti-diarrheal, proton pump inhibitors, H2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory, and anti-emetics. On the basis of indication, the market is segmented into gastroesophageal reflux disease (GERD) or heartburn, constipation, diarrhea, motion sickness, and flatulence. On the basis of end user, it is categorized into clinics, pharmacies, hospitals, and others. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operate in this market include Johnson & Johnson, GlaxoSmithKline Plc., Bayer AG, Sanofi, Abbott Laboratories, Pfizer Inc., Prestige Brands, Inc., Boehringer Ingelheim GmbH, Procter & Gamble, and Purdue Pharma L.P.

Key Benefits

  • The study provides an in-depth analysis of the global gastrointestinal OTC drugs market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the global gastrointestinal OTC drugs market¬†which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the global gastrointestinal OTC drugs market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global gastrointestinal OTC drugs market.

Gastrointestinal OTC Drugs Market Report Highlights

Aspects Details
Gastrointestinal OTC Drugs Market By Product
By Product
  • Laxatives
  • Gastrointestinal Cancer Treatments
  • Gastric Acid Reducers
  • Anti-Diarrheal
  • Proton Pump Inhibitors
  • H2 Inhibitors
  • Gastric Acid Neutralizers
  • Bowel Anti-Inflammatory
  • Anti-Emetics
Gastrointestinal OTC Drugs Market By Indication
By Indication
  • Gastroesophageal Reflux Disease (GERD) or Heartburn
  • Constipation
  • Diarrhea
  • Motion Sickness
  • Flatulence
Gastrointestinal OTC Drugs Market By End User
By End User
  • Clinics
  • Pharmacies
  • Hospitals
  • Others
Gastrointestinal OTC Drugs Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Procter & Gamble, Prestige Brands, Inc., Purdue Pharma L.P, Johnson & Johnson, Pfizer Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, Bayer AG, GlaxoSmithKline Plc., Sanofi

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Gastrointestinal OTC Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032